A detailed history of Silvercrest Asset Management Group LLC transactions in Profound Medical Corp. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 15,001 shares of PROF stock, worth $105,007. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,001
Previous 15,001 -0.0%
Holding current value
$105,007
Previous $125,000 4.8%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$7.25 - $9.07 $108,757 - $136,059
-15,001 Reduced 50.0%
15,001 $125,000
Q2 2024

Aug 14, 2024

BUY
$7.25 - $9.07 $108,757 - $136,059
15,001 Added 100.0%
30,002 $251,000
Q1 2024

May 15, 2024

SELL
$7.3 - $9.46 $379,600 - $491,920
-52,000 Reduced 77.61%
15,001 $127,000
Q4 2023

Feb 14, 2024

BUY
$7.85 - $11.18 $525,957 - $749,071
67,001 New
67,001 $568,000

Others Institutions Holding PROF

About Profound Medical Corp.


  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $146M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.